In pancreatic cancer, Tuntithavornwat et al. demonstrated that pancreatic cancer cells with OBSCN expression loss induced cytoskeletal remodeling through downregulation of RhoA activity, thus accelerating cell migration, enhancing motility, and EMT [11]. This evidence concerns the gene RHOA and pancreatic neoplasm.